Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT05317481
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - 29 Years
Healthy Volunteers
Not accepted

Interventions

  • BE-SMART-DR — BEHAVIORAL
    Therapy that provides self-directed strategies to regularize sleep and other DRs to reduce short-term suicide risk that can be used lifelong to potentially also reduce long-term suicide risk
  • psychoeducational control comparator condition (CC) — BEHAVIORAL
    Structured sessions, matched for BE-SMART-DR session number and time, that will emphasize established strategies to manage health and well being

Study Details

The purpose of this study is to advance a non-pharmacologic suicide preventive intervention with wide dissemination potential as an innovative high-yield solution to reduce suicide rates. The investigators aim to achieve this with this study of Brain Emotion Circuitry Self-Monitoring and Regulation Therapy for Daily Rhythms (BE-SMART-DR), that provides self-directed strategies to regularize sleep and other DRs to reduce short-term suicide risk that can be used lifelong to potentially also reduce long-term suicide risk.

Key Dates

Start date
Apr 1, 2022
Status verified
Mar 2026
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025

Study Design

Enrollment
65 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: BE-SMART-DR
    Participation will include research clinical/behavioral interviews and symptom self-ratings, magnetic resonance imaging (MRI) scanning, actigraphy wearables, and use of smart phones for ecological momentary assessment (EMA). Subjects will participate in 12 weekly sessions and 6-month in person follow-up.
  • Active Comparator: control comparator condition
    Matched for experimental, participation will include research clinical/behavioral interviews and symptom self-ratings, magnetic resonance imaging (MRI) scanning, actigraphy wearables, and use of smart phones for ecological momentary assessment (EMA). Subjects will participate in 12 weekly sessions and 6-month in person follow-up.

Primary Outcome Measure

Mean Score Measuring Suicidal Ideation/Propensity (SI/P) Using Concise Health Risk Tracking Scale-Self Reported (CHRT-SR) to Assess for Propensity [ Time Frame: Baseline (pre- intervention), 6 weeks (midpoint of intervention), 12 weeks (immediately after the intervention) ]

Locations (2)

FacilityCityStateZIPSite coordinators
Magnetic Resonance Research CenterNew HavenConnecticut06510-
Mood Disorders Research ProgramNew HavenConnecticut06510-

Find similar trials in New Haven, CT

By condition
Bipolar disorderDepression
By specialty
PsychiatryMental healthBehavioral health
By research site
Magnetic Resonance Research Center· New Haven, CTMood Disorders Research Program· New Haven, CT

Related Studies